Insider Transactions last 24 months for Regeneron Pharmaceuticals, Inc.  -  NSDQ: REGN

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Sing George LDirector01/02/2025AADirectCOM166$0.00$0.0027,828
Bassler Bonnie LDirector01/02/2025AADirectCOM166$0.00$0.001,548
Brown Michael SDirector01/02/2025AADirectCOM166$0.00$0.001,548
Goldstein Joseph LDirector01/02/2025AADirectCOM166$0.00$0.006,548
Guarini KathrynDirector01/02/2025AADirectCOM166$0.00$0.00448
Poon Christine ADirector01/02/2025AADirectCOM166$0.00$0.002,352
Ryan Arthur FDirector01/02/2025AADirectCOM166$0.00$0.0017,748
Zoghbi Huda YDirector01/02/2025AADirectCOM166$0.00$0.001,548
Coles N AnthonyDirector01/02/2025AADirectCOM166$0.00$0.001,559
Thompson Craig B.Director01/02/2025AADirectCOM166$0.00$0.00620
Schenkein David PDirector01/02/2025AADirectCOM166$0.00$0.00448
Sing George LDirector12/31/2024DFDirectCOM1,948$708.19$1,379,554.1227,662
Sing George LDirector12/31/2024AMDirectCOM3,338$413.33$1,379,695.5429,610
Poon Christine ADirector12/20/2024AWDirectCOM14$0.00$0.002,186
Fenimore Christopher R.SVP Finance & CFO12/16/2024DFDirectCOM491$730.81$358,827.7116,265
Larosa Joseph JEVP General Counsel and Secret12/16/2024DFDirectCOM702$730.81$513,028.6230,075
Mccourt MarionEVP Commercial12/16/2024DFDirectCOM759$730.81$554,684.7914,230
Murphy Andrew JEVP Research12/16/2024DFDirectCOM1,054$730.81$770,273.7449,074
Pitofsky JasonVP Controller12/16/2024DFDirectCOM298$730.81$217,781.384,664
Stahl NeilEVP Research and Development12/16/2024DFDirectCOM304$730.81$222,166.2448,829
Van Plew Daniel PEVP & General Mgr, Industrial12/16/2024DFDirectCOM969$730.81$708,154.8934,792
Murphy Andrew JEVP Research11/08/2024DGDirectCOM1,185$0.00$0.0047,121
Mccourt MarionEVP Commercial11/01/2024DSDirectCOM1,000$844.61$844,610.0012,931
Mccourt MarionEVP Commercial11/01/2024AMDirectCOM1,000$381.40$381,400.0013,931
Mccourt MarionEVP Commercial10/01/2024DSDirectCOM1,000$1,054.06$1,054,060.0012,931
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 23 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel